基于智能手机的个性化生活方式干预对初级保健抑郁症状的成本效果:LIDIAS整群随机对照试验方案
本研究为多中心整群随机对照试验方案,在荷兰全科诊所比较常规照护加个性化eHealth生活方式干预(PLI)与常规照护加监测应用对抑郁症状患者的效果。主要结局为PHQ-9抑郁症状严重度变化,每臂招募105例PHQ-9≥5患者,并评估成本效果。
要点
- 在初级保健中比较PLI与监测应用对抑郁症状的(成本)效果。
- 主要结局为PHQ-9评估的抑郁症状严重度变化。
- 每臂招募105例PHQ-9≥5患者,随访6个月干预。
核心结论
- 该试验旨在评估数字生活方式支持工具对初级保健抑郁症状患者的临床与经济影响。
研究设计与样本
- 多中心、整群随机对照试验,在荷兰全科诊所开展,按地区和区域社会经济地位分层1:1随机。
- 干预组为常规照护加PLI,对照组为常规照护加监测应用,每臂招募105例PHQ-9≥5患者。
关键数值与推荐
- 主要结局为PHQ-9评估的抑郁症状严重度变化。
- 次要结局包括生活方式行为、焦虑症状、治疗满意度、心理健康相关生活质量、社会支持、药物使用及医疗服务利用等。
- PLI组患者使用应用6个月设定生活方式目标、监测行为及抑郁焦虑症状。
临床怎么用
- 结果为数字生活方式支持工具在初级保健抑郁症状管理中的可及性、个性化和可持续性提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression is common and mostly managed in primary care. In the Netherlands, general practitioners (GPs) and mental health nurses (GP-MHNs) generally start with education and lifestyle advice, yet the latter remains underused despite evidence of its effectiveness. Smartphone-based eHealth tools may help integrate lifestyle interventions into routine care by offering personalized support and monitoring. This study evaluates the (cost-)effectiveness of a Personalized eHealth Lifestyle Intervention (PLI) delivered via a smartphone app for patients with symptoms of depression in primary care. METHODS: This multicenter, cluster-randomized controlled trial will be conducted in Dutch general practices. Practices will be randomized (1:1), stratified by region and area-level socioeconomic status, into two groups: (1) intervention group including care as usual plus the PLI, or (2) control group including care as usual plus a monitoring app. Within the PLI, patients will use an app for 6 months to set lifestyle goals, monitor progress in lifestyle behavior, and track symptoms of depression and anxiety. GPs and GP-MHNs will have access to patient progress through a web-based version. Control group patients will use a similar app for symptom tracking only. The primary outcome is the change in severity of symptoms of depression assessed with the Patient Health Questionnaire-9 (PHQ-9). Secondary outcomes include lifestyle behaviors, satisfaction with lifestyle, anxiety symptoms, patient satisfaction with treatment by GP and GP-MHNs, mental health-related quality of life, social support, use of antidepressants, use of anxiolytics, and utilization of medical and mental health services. Cost-effectiveness will also be evaluated. A total of 105 patients per arm (PHQ-9 ≥ 5) will be recruited. DISCUSSION: The results of this study will provide valuable insights into the clinical and economic impact of a digital lifestyle support tool. This trial aims to contribute to more accessible, personalized, sustainable, and cost-effective care for people with symptoms of depression in primary care. TRIAL REGISTRATION: ClinicalTrials.gov NCT07022184. Registered on June 22, 2025.
引用
- Jagtenberg EM, Ligthart SA, Muilwijk OG, et al. Cost-effectiveness of a smartphone-based personalized lifestyle intervention for symptoms of depression in primary care: protocol for a cluster-randomized controlled trial (LIDIAS). Trials. 2026. PMID: 42157297. doi:10.1186/s13063-026-09786-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。